We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.49%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$58.1B
AUM Growth
+$5.28B
(+10%)
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
1.82%
Top 10 Holdings %
Top 10 Hldgs %
14.06%
Holding
4,799
New
857
Increased
1,497
Reduced
1,529
Closed
854
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$701M |
| 2 |
Pinduoduo
PDD
|
+$159M |
| 3 |
CrowdStrike
CRWD
|
+$152M |
| 4 |
UnitedHealth
UNH
|
+$143M |
| 5 |
SPDR Gold Trust
GLD
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.17B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$240M |
| 3 |
Microsoft
MSFT
|
+$184M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 5 |
Ulta Beauty
ULTA
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.49% |
| 2 | Consumer Discretionary | 6.34% |
| 3 | Healthcare | 4.58% |
| 4 | Financials | 4.54% |
| 5 | Industrials | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Viridian Therapeutics
VRDN
$2.13B
| $472K | ﹤0.01% |
+26,956
| New | +$523K |
|
|
EMBJ
3077
Embraer S.A. ADS
EMBJ
$11.6B
| $471K | ﹤0.01% |
17,687
-4,153
| -19% | -$82.4K |
|
3078
Talkspace
TALK
$873M
| $471K | ﹤0.01% |
+131,961
| New | +$359K |
|
3079
iShares MSCI Australia ETF
EWA
$1.34B
| $471K | ﹤0.01% |
+19,098
| New | +$456K |
|
3080
Ituran Location and Control
ITRN
$1.08B
| $470K | ﹤0.01% |
+16,799
| New | +$444K |
|
3081
Vaalco Energy
EGY
$594M
| $468K | ﹤0.01% |
+67,211
| New | +$315K |
|
|
TERN
3082
DELISTED
Terns Pharmaceuticals
TERN
| $468K | ﹤0.01% |
+71,361
| New | +$466K |
|
3083
Rigetti Computing
RGTI
$4.7B
| $468K | ﹤0.01% |
305,582
+144,875
| +90% | +$209K |
|
3084
PUT
The Mosaic Company
MOS
$7.09B
| $467K | ﹤0.01% |
14,400
-253,500
| -95% | -$8.07M |
|
3085
Alignment Healthcare
ALHC
$4.02B
| $467K | ﹤0.01% |
+94,235
| New | +$603K |
|
3086
Live Oak Bancshares
LOB
$1.95B
| $467K | ﹤0.01% |
+11,252
| New | +$448K |
|
3087
CALL
Elevance Health
ELV
$81.9B
| $467K | ﹤0.01% |
900
-2,300
| -72% | -$1.14M |
|
3088
ThredUp
TDUP
$736M
| $466K | ﹤0.01% |
233,202
-14,818
| -6% | -$30.2K |
|
3089
Akebia Therapeutics
AKBA
$327M
| $466K | ﹤0.01% |
254,664
+224,108
| +733% | +$358K |
|
3090
4D Molecular Therapeutics
FDMT
$526M
| $466K | ﹤0.01% |
+14,619
| New | +$373K |
|
3091
First Industrial Realty Trust
FR
$8.88B
| $465K | ﹤0.01% |
+8,848
| New | +$467K |
|
|
PARAA
3092
DELISTED
Paramount Global Class A
PARAA
| $464K | ﹤0.01% |
21,245
+565
| +3% | +$11.7K |
|
3093
Telos
TLS
$337M
| $464K | ﹤0.01% |
111,472
-18,317
| -14% | -$72.6K |
|
3094
Marqeta
MQ
$1.8B
| $461K | ﹤0.01% |
19,341
+14,033
| +264% | +$347K |
|
3095
Integra LifeSciences
IART
$1.54B
| $461K | ﹤0.01% |
12,993
-26,150
| -67% | -$1.05M |
|
3096
Fiverr
FVRR
$376M
| $460K | ﹤0.01% |
21,845
-10,402
| -32% | -$260K |
|
3097
PUT
Vertex Pharmaceuticals
VRTX
$121B
| $460K | ﹤0.01% |
+1,100
| New | +$465K |
|
3098
Acumen Pharmaceuticals
ABOS
$154M
| $459K | ﹤0.01% |
113,232
+60,403
| +114% | +$228K |
|
3099
CytomX Therapeutics
CTMX
$705M
| $458K | ﹤0.01% |
210,151
+59,618
| +40% | +$110K |
|
3100
PUT
Ternium
TX
$9.29B
| $458K | ﹤0.01% |
+11,000
| New | +$436K |
|
Similar funds
Squarepoint's Q1 2024 Portfolio in Review
As of Q1 2024, Squarepoint held 4,799 positions worth $58.1B, up 10% from $52.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Squarepoint's Q1 2024 filing shows 857 new, 1,497 increased, 1,529 reduced and 854 closed positions. Its largest new stake was The Gap Inc: 3,316,943 shares worth $91.4M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 9.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Squarepoint's largest Q1 2024 buy was The Gap Inc: 3,316,943 shares worth $91.4M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q1 2024, an estimated $701M increase.
- Squarepoint's biggest Q1 2024 reduction was Invesco QQQ Trust, cutting an estimated $240M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q1 2024, selling an estimated $1.17B.
- Squarepoint's ten largest holdings make up 14% of its $58.1B portfolio in Q1 2024.
- Squarepoint opened 857 new positions and closed 854 in Q1 2024.
- Squarepoint's portfolio value rose 10% quarter-over-quarter to $58.1B.
Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.